Odyssey Health (ODYY) EPS (Basic) Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.72% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -1.10% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.43% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.44% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 58.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 26.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 5.98% |
| 10 | Odyssey Health | - | - | - | -14.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -14.47% |
| Oct 31, 2025 | 49.96% |
| Jul 31, 2025 | 20.63% |
| Apr 30, 2025 | 60.83% |
| Jan 31, 2025 | 52.81% |
| Oct 31, 2024 | 20.63% |
| Jul 31, 2024 | -67.11% |
| Apr 30, 2024 | 57.47% |
| Jan 31, 2024 | 151.98% |
| Oct 31, 2023 | 0.00% |
| Jul 31, 2023 | 30.66% |
| Apr 30, 2023 | -25.99% |
| Jan 31, 2023 | -25.99% |
| Oct 31, 2022 | -14.47% |
| Jul 31, 2022 | 61.11% |
| Jan 31, 2022 | -129.92% |
| Oct 31, 2021 | -160.48% |
| Jul 31, 2021 | -228.75% |
| Apr 30, 2021 | -496.06% |
| Jan 31, 2021 | -66.92% |
| Oct 31, 2020 | -32.77% |
| Jul 31, 2020 | -275.99% |
| Apr 30, 2020 | -143.02% |
| Jan 31, 2020 | -232.74% |
| Oct 31, 2019 | -371.68% |
| Jul 31, 2019 | -919.35% |
| Jan 31, 2019 | -127.18% |
| Oct 31, 2018 | -73.20% |
| Jul 31, 2018 | -59.10% |
| Apr 30, 2018 | -18.35% |
| Jan 31, 2018 | -69.51% |
| Oct 31, 2017 | -124.25% |